Overview
- The outbreak totaled 53 confirmed infections, 11 probable cases and 45 deaths, according to WHO and national data.
- The event was first declared on September 4 in the Bulape health zone of Kasai Province, and the last patient left care on October 19.
- More than 47,500 people received Merck’s Ervebo through a ring‑vaccination strategy, supported by roughly 48,000 additional doses from global stockpiles managed with Gavi and the ICG.
- Authorities credit strengthened surveillance, rapid contact tracing and case management—supported by 112 WHO responders and over 150 tonnes of supplies—for containing spread in a hard‑to‑reach area.
- Officials will maintain heightened monitoring for 90 days and continue survivor care, with WHO supporting vigilance in case of flare‑ups.